A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines
Clinical trial NCT05248880 · COMPLETED
Trial details
- NCT number
- NCT05248880
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-08
- Primary completion
- 2023-02-01
- Enrollment
- 309
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.